BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11180054)

  • 1. Molecular dynamics simulation of the calmodulin-trifluoperazine complex in aqueous solution.
    Yamaotsu N; Suga M; Hirono S
    Biopolymers; 2001 Apr; 58(4):410-21. PubMed ID: 11180054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of antagonists with calmodulin: insights from molecular dynamics simulations.
    Kövesi I; Menyhárd DK; Laberge M; Fidy J
    J Med Chem; 2008 Jun; 51(11):3081-93. PubMed ID: 18459732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexes formed between calmodulin and the antagonists J-8 and TFP in solution.
    Craven CJ; Whitehead B; Jones SK; Thulin E; Blackburn GM; Waltho JP
    Biochemistry; 1996 Aug; 35(32):10287-99. PubMed ID: 8756684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+-bound calmodulin forms a compact globular structure on binding four trifluoperazine molecules in solution.
    Matsushima N; Hayashi N; Jinbo Y; Izumi Y
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):211-5. PubMed ID: 10727421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous binding of drugs with different chemical structures to Ca2+-calmodulin: crystallographic and spectroscopic studies.
    Vertessy BG; Harmat V; Böcskei Z; Náray-Szabó G; Orosz F; Ovádi J
    Biochemistry; 1998 Nov; 37(44):15300-10. PubMed ID: 9799490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of a MARCKS peptide containing the calmodulin-binding domain in complex with Ca2+-calmodulin.
    Yamauchi E; Nakatsu T; Matsubara M; Kato H; Taniguchi H
    Nat Struct Biol; 2003 Mar; 10(3):226-31. PubMed ID: 12577052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug binding by calmodulin: crystal structure of a calmodulin-trifluoperazine complex.
    Cook WJ; Walter LJ; Walter MR
    Biochemistry; 1994 Dec; 33(51):15259-65. PubMed ID: 7803388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical studies of the binding of trifluoperazine derivatives to site (82-93) of calmodulin: effect of lengthenings of the methylene linker chain on the binding affinity.
    Gresh N
    Mol Pharmacol; 1987 Jun; 31(6):617-22. PubMed ID: 3600606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complex structure of calmodulin bound to a calcineurin peptide.
    Ye Q; Wang H; Zheng J; Wei Q; Jia Z
    Proteins; 2008 Oct; 73(1):19-27. PubMed ID: 18384083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution X-ray scattering reveals a novel structure of calmodulin complexed with a binding domain peptide from the HIV-1 matrix protein p17.
    Izumi Y; Watanabe H; Watanabe N; Aoyama A; Jinbo Y; Hayashi N
    Biochemistry; 2008 Jul; 47(27):7158-66. PubMed ID: 18553937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conformational plasticity of calmodulin upon calcium complexation gives a model of its interaction with the oedema factor of Bacillus anthracis.
    Laine E; Yoneda JD; Blondel A; Malliavin TE
    Proteins; 2008 Jun; 71(4):1813-29. PubMed ID: 18175311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target-induced conformational adaptation of calmodulin revealed by the crystal structure of a complex with nematode Ca(2+)/calmodulin-dependent kinase kinase peptide.
    Kurokawa H; Osawa M; Kurihara H; Katayama N; Tokumitsu H; Swindells MB; Kainosho M; Ikura M
    J Mol Biol; 2001 Sep; 312(1):59-68. PubMed ID: 11545585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new potent calmodulin antagonist with arylalkylamine structure: crystallographic, spectroscopic and functional studies.
    Harmat V; Böcskei Z; Náray-Szabó G; Bata I; Csutor AS; Hermecz I; Arányi P; Szabó B; Liliom K; Vértessy BG; Ovádi J
    J Mol Biol; 2000 Mar; 297(3):747-55. PubMed ID: 10731425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing orientations of the anti-psychotic drug trifluoperazine selected by alternate conformations of M144 in calmodulin.
    Feldkamp MD; Gakhar L; Pandey N; Shea MA
    Proteins; 2015 May; 83(5):989-96. PubMed ID: 25694384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric effects of the antipsychotic drug trifluoperazine on the energetics of calcium binding by calmodulin.
    Feldkamp MD; O'Donnell SE; Yu L; Shea MA
    Proteins; 2010 Aug; 78(10):2265-82. PubMed ID: 20544963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of calmodulin-W-7 complex: the basis of diversity in molecular recognition.
    Osawa M; Swindells MB; Tanikawa J; Tanaka T; Mase T; Furuya T; Ikura M
    J Mol Biol; 1998 Feb; 276(1):165-76. PubMed ID: 9514729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of calmodulin bound to a calcineurin peptide: a new way of making an old binding mode.
    Ye Q; Li X; Wong A; Wei Q; Jia Z
    Biochemistry; 2006 Jan; 45(3):738-45. PubMed ID: 16411749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin.
    Schumacher MA; Rivard AF; Bächinger HP; Adelman JP
    Nature; 2001 Apr; 410(6832):1120-4. PubMed ID: 11323678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of negative and positive ion electrospray ionization mass spectra of calmodulin and its complex with trifluoperazine.
    Watt SJ; Oakley A; Sheil MM; Beck JL
    Rapid Commun Mass Spectrom; 2005; 19(15):2123-30. PubMed ID: 15988725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-induced dimer formation of calmodulin.
    Zhang Y; Tan H; Jia Z; Chen G
    J Mol Recognit; 2008; 21(4):267-74. PubMed ID: 18461636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.